Chudasama, Y. V., Khunti, K. ., Coles, B. ., Gillies, C. L., Islam, N. ., Rowlands, A. V., … Zaccardi, F. . (2023). Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study. Nutr Metab Cardiovasc Dis. http://doi.org/10.1016/j.numecd.2023.04.003
K. Khunti
First name
K.
Last name
Khunti
Conrad, N. ., Misra, S. ., . Y. Verbakel, J. ., Verbeke, G. ., Molenberghs, G. ., Taylor, P. N., … Cambridge, G. . (2023). Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. http://doi.org/10.1016/s0140-6736(23)00457-9
Ling, S. ., Zaccardi, F. ., Issa, E. ., Davies, M. J., Khunti, K. ., & Brown, K. . (2023). Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England. Diabetologia. http://doi.org/10.1007/s00125-022-05854-8
Meffen, A. ., Sayers, R. D., Gillies, C. L., Khunti, K. ., & Gray, L. J. (2022). Are major lower extremity amputations well recorded in primary care electronic health records?: Insights from primary care electronic health records in England. Prim Health Care Res Dev, 23, e77. http://doi.org/10.1017/s1463423622000718
Mizani, M. A., Dashtban, A. ., Pasea, L. ., Lai, A. G., Thygesen, J. ., Tomlinson, C. ., … Banerjee, A. . (2022). Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort study. J R Soc Med, 1410768221131897. http://doi.org/10.1177/01410768221131897
Karsanji, U. ., Evans, R. A., Quint, J. K., Khunti, K. ., Lawson, C. A., Petherick, E. ., … Steiner, M. C. (2022). Mortality associated with metabolic syndrome in people with COPD managed in primary care. ERJ Open Res, 8. http://doi.org/10.1183/23120541.00211-2022
Bidulka, P. ., Mathur, R. ., Lugo-Palacios, D. G., O’Neill, S. ., Basu, A. ., Silverwood, R. J., … Grieve, R. . (2022). Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment in people with type 2 diabetes in England: a cross-sectional study. Diabetes Obes Metab. http://doi.org/10.1111/dom.14874
Idris, I. ., Zhang, R. ., Mamza, J. B., Ford, M. ., Morris, T. ., Banerjee, A. ., & Khunti, K. . (2021). Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease. Diabetes Obes Metab, 23, 2207–2214. http://doi.org/10.1111/dom.14437
Wilkinson, T. J., Miksza, J. ., Zaccardi, F. ., Lawson, C. ., Nixon, A. C., Young, H. M. L., … Smith, A. C. (2022). Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease. J Cachexia Sarcopenia Muscle. http://doi.org/10.1002/jcsm.13047
Idris, I. ., Zhang, R. ., Mamza, J. B., Ford, M. ., Morris, T. ., Banerjee, A. ., & Khunti, K. . (2022). Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting. Diabetes Obes Metab. http://doi.org/10.1111/dom.14799